Thomas M. Holl

521 total citations
7 papers, 423 citations indexed

About

Thomas M. Holl is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Thomas M. Holl has authored 7 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Thomas M. Holl's work include Diabetes and associated disorders (4 papers), Immune Cell Function and Interaction (4 papers) and T-cell and B-cell Immunology (3 papers). Thomas M. Holl is often cited by papers focused on Diabetes and associated disorders (4 papers), Immune Cell Function and Interaction (4 papers) and T-cell and B-cell Immunology (3 papers). Thomas M. Holl collaborates with scholars based in United States, Switzerland and Germany. Thomas M. Holl's co-authors include David Serreze, Manuela Gehring, Robert H. Eibl, Luigi Mariani, Martin Reichel, Harold D. Chapman, Otmar D. Wiestler, Manfred Schwab, Hiroko Ohgaki and Gurdyal S. Besra and has published in prestigious journals such as The Journal of Immunology, Carcinogenesis and Molecular Carcinogenesis.

In The Last Decade

Thomas M. Holl

7 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas M. Holl United States	7	177	149	112	96	90	7	423
Katrin Hafen Switzerland	11	463 2.6×	73 0.5×	183 1.6×	113 1.2×	26 0.3×	13	700
Lauren A. Solomon Canada	14	121 0.7×	65 0.4×	260 2.3×	62 0.6×	91 1.0×	22	483
Margaret L. McKinnon Canada	12	106 0.6×	117 0.8×	332 3.0×	52 0.5×	43 0.5×	14	603
Promita Bose United States	9	51 0.3×	103 0.7×	167 1.5×	181 1.9×	63 0.7×	12	448
Sho Ohta Japan	12	143 0.8×	62 0.4×	307 2.7×	55 0.6×	21 0.2×	31	531
Hugo Caldas United States	9	141 0.8×	47 0.3×	501 4.5×	184 1.9×	31 0.3×	9	608
michel schmid France	9	158 0.9×	76 0.5×	172 1.5×	69 0.7×	36 0.4×	12	413
Sangeeta R. Iyer United States	5	217 1.2×	87 0.6×	326 2.9×	63 0.7×	36 0.4×	5	602
Nyam‐Osor Chimge United States	13	138 0.8×	77 0.5×	246 2.2×	85 0.9×	25 0.3×	23	533
Cornelia Schuster Norway	9	118 0.7×	64 0.4×	106 0.9×	99 1.0×	12 0.1×	22	315

Countries citing papers authored by Thomas M. Holl

Since Specialization

Citations

This map shows the geographic impact of Thomas M. Holl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Holl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Holl more than expected).

Fields of papers citing papers by Thomas M. Holl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Holl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Holl. The network helps show where Thomas M. Holl may publish in the future.

Co-authorship network of co-authors of Thomas M. Holl

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Holl. A scholar is included among the top collaborators of Thomas M. Holl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Holl. Thomas M. Holl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Holl, Thomas M., Harold D. Chapman, Gurdyal S. Besra, et al.. (2005). Activated NKT Cells Inhibit Autoimmune Diabetes through Tolerogenic Recruitment of Dendritic Cells to Pancreatic Lymph Nodes. The Journal of Immunology. 174(3). 1196–1204. 117 indexed citations

2.

Serreze, David, Thomas M. Holl, Michele P. Marron, et al.. (2004). MHC Class II Molecules Play a Role in the Selection of Autoreactive Class I-Restricted CD8 T Cells That Are Essential Contributors to Type 1 Diabetes Development in Nonobese Diabetic Mice. The Journal of Immunology. 172(2). 871–879. 36 indexed citations

3.

Holl, Thomas M., et al.. (2004). Enhanced Pathogenicity of Diabetogenic T Cells Escaping a Non-MHC Gene-Controlled Near Death Experience. The Journal of Immunology. 173(6). 3791–3800. 41 indexed citations

4.

Takaki, Toshiyuki, Scott M. Lieberman, Thomas M. Holl, et al.. (2004). Requirement for Both H-2Db and H-2Kd for the Induction of Diabetes by the Promiscuous CD8+ T Cell Clonotype AI4. The Journal of Immunology. 173(4). 2530–2541. 25 indexed citations

5.

Kleihues, Paul, Hideaki Ohgaki, Robert H. Eibl, et al.. (1994). Type and Frequency of p53 Mutations in Tumors of the Nervous System and Its Coverings. Recent results in cancer research. 135. 25–31. 15 indexed citations

6.

Ohgaki, Hiroko, Robert H. Eibl, Martin Reichel, et al.. (1993). Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system. Molecular Carcinogenesis. 8(2). 74–80. 182 indexed citations

7.

Brüstle, Oliver, Iver Petersen, H. Radner, et al.. (1993). SHORT COMMUNICATION: Complementary tumor induction in neural grafts exposed to N-ethyl-N-nitrosourea and an activated myc gene. Carcinogenesis. 14(8). 1715–1718. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact